6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 6 of 6 clinical reviews.
A clinical deep-dive into flibanserin (Addyi) adverse events stratified by patient phenotype, including CNS sensitivity, alcohol use, CYP2C19 metabolism, and comorbidity burden, with trial data, FAERS analysis, and dosing guidance.
A clinical deep-dive into flibanserin (Addyi) delayed-onset side effects, including dizziness, hypotension, CNS depression, and rare FAERS-reported reactions, with prescribing guidance and monitoring tips.
A physician-reviewed breakdown of flibanserin (Addyi) adverse event rates from phase III trials, FDA review documents, FAERS data, and post-market literature, with exact percentages, named studies, and clinical guidance.
A physician-reviewed look at Addyi (flibanserin) side effects, including rare and potentially lasting adverse events, drawn from clinical trials, FDA labeling, and FAERS post-market data.
A clinical deep-dive into the rare but serious adverse events associated with flibanserin (Addyi), including syncope, CNS depression, and hypotension, with data from FDA labeling, FAERS, and post-market surveillance.
A clinician-reviewed guide to flibanserin (Addyi) withdrawal and discontinuation syndrome, covering mechanism, documented adverse events, FAERS data, clinical trial findings, and how to stop safely.